Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States

JJ Kim, SJ Goldie - Bmj, 2009 - bmj.com
Objective To assess the cost effectiveness of including preadolescent boys in a routine
human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost …

Economic evaluation of human papillomavirus vaccination in the United Kingdom

M Jit, YH Choi, WJ Edmunds - Bmj, 2008 - bmj.com
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Challenges of implementing human papillomavirus (HPV) vaccination policy

AE Raffle - Bmj, 2007 - bmj.com
Challenges of implementing human papillomavirus (HPV) vaccination policy | The BMJ Skip to
main content Intended for healthcare professionals Access provided by Google Indexer …

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl …

AL Pearson, G Kvizhinadze, N Wilson, M Smith… - BMC infectious …, 2014 - Springer
Background Similar to many developed countries, vaccination against human
papillomavirus (HPV) is provided only to girls in New Zealand and coverage is relatively low …

Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK

S Datta, J Pink, GF Medley, S Petrou… - BMC infectious …, 2019 - Springer
Background Human papillomavirus (HPV) is the most widespread sexually transmitted
infection worldwide. It causes several health consequences, in particular accounting for the …

The cost effectiveness of human papillomavirus vaccines: a systematic review

K Seto, F Marra, A Raymakers, CA Marra - Drugs, 2012 - Springer
Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Economic evaluation of human papillomavirus vaccination in developed countries

M Brisson, N Van de Velde, MC Boily - Public health genomics, 2009 - karger.com
Background: With promising efficacy results from randomized control trials of human
papillomavirus (HPV) vaccines and the availability of new screening paradigms …

Cost-effectiveness analyses of human papillomavirus vaccination

AT Newall, P Beutels, JG Wood… - The Lancet infectious …, 2007 - thelancet.com
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

L Brabin, SA Roberts, R Stretch, D Baxter, G Chambers… - Bmj, 2008 - bmj.com
Objective To assess the feasibility and acceptability of delivering a human papillomavirus
(HPV) vaccine to adolescent girls. Design Prospective cohort study. Setting 36 secondary …

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys

EA Burger, S Sy, M Nygård, IS Kristiansen, JJ Kim - PloS one, 2014 - journals.plos.org
Background Increasingly, countries have introduced female vaccination against human
papillomavirus (HPV), causally linked to several cancers and genital warts, but few have …